AQS Consulting

FDA Regulatory & Quality Systems Experts

Defensible. Proven. Trusted.

AQS Consulting Inc. provides expert-led regulatory and quality management systems solutions across FDA-regulated industries, delivering systems that are not only compliant, but defensible, scalable, and built for real-world execution. This includes end-to-end support for achieving cGMP compliance and successful third-party certification and marketplace approval for Amazon and other retail platforms.

100%
Pass Rate
500+
Audits & Remediation Projects
25+
Years Experience
400+
Clients Served
Aisha Siddiqui, President & CEO of AQS Consulting

Meet your consultant

Aisha Siddiqui, President & CEO

AQS is led by Aisha Siddiqui, an ASQ Certified Quality Manager, Certified Quality Auditor and PCQI. Before founding AQS in 2020, she spent seven years at The Nature's Bounty Co., rising to Director of Quality and Certifications.

  • ASQ Certified Quality Manager
  • ASQ Certified Quality Auditor
  • PCQI
  • B.S. Biomedical Engineering, MBA

Get Your Quality Systems Built, Implemented, and Inspection-Ready. Fast.

AQS Consulting Inc. works directly with your team to design, implement, and operationalize quality management systems across FDA-regulated industries. Whether you are building from the ground up, remediating gaps, or preparing for certification or inspection, we deliver systems that are fully compliant, defensible, and ready for real-world execution.

  • cGMP compliance (21 CFR 111, 117, 210/211)
  • Third-party certification and audit readiness (including Amazon requirements)
  • Full quality system development and remediation

Built for Speed. Designed for Execution.

We integrate directly into your operations without unnecessary layers, delays, or handoffs.

No unnecessary middle management
No handoffs between teams
No generic recommendations

We work side-by-side with your team to move projects forward quickly, implement solutions in real time, and deliver measurable progress from day one.

Our approach is simple: identify, fix, implement, and close.

What to Expect When Working with AQS

From the start, we provide full transparency and a clear path forward. You will understand:

  • What needs to be done to achieve compliance or certification
  • The gaps in your current systems
  • The timeline and level of effort required
  • How we will execute and deliver results

We don't just assess. We take ownership of execution and drive projects through completion.

Our Approach

1

Diagnostic Audit

Systematic evaluation of your regulatory posture against FDA requirements, identifying gaps and quantifying risk before they become findings.

2

System Architecture

Engineering robust quality management systems, SOPs, and compliance frameworks tailored to your scale and operational reality.

3

Strategic Integration

Embedding systems directly into your operations, working side-by-side with your team to ensure adoption and execution.

4

Sustainable Compliance

Ensuring inspection readiness, certification success, and long-term regulatory sustainability that outlasts any single audit.

We stay engaged until your systems are implemented, operational, and inspected or certified.

Defensible Compliance in High-Stakes Environments

Our work is built to stand up to FDA inspections, third-party audits and certifications, legal and expert review. We ensure your systems are not only compliant, but defensible, sustainable, and aligned with real-world operations.

Turn Compliance Challenges into Sustainable, Defensible Systems

When compliance issues arise, speed, expertise, and execution matter. AQS Consulting Inc. deploys experienced remediation teams, including professionals with direct FDA experience, to rapidly stabilize operations while building long-term, inspection-ready solutions. We don't just respond to issues. We resolve them at the root and implement systems designed to withstand ongoing regulatory scrutiny.

Crisis & Enforcement

Rapid Response

Enforcement Defense & 483 Remediation

Rapid response and technical strategy to address FDA inspectional findings. We build defensible remediation plans that satisfy agency requirements and protect your license to operate.

Rapid Response

Critical Enforcement Strategy

High-stakes advisory for Warning Letters and Consent Decrees. We provide the senior expertise required to navigate complex legal and regulatory mandates while maintaining business continuity.

Rapid Response

Supply Chain Recovery & Import Alerts

Specialized support for detained shipments and red-list removals. We verify your foreign supplier compliance (FSVP) and resolve the bottlenecks keeping your products at the border.

Systems & Readiness

QMS Architecture & SOP Design

Engineering robust Quality Management Systems tailored to your scale. We move beyond paper compliance to build functional, lean SOPs that actually work for your team.

Diagnostic Audits & Risk Assessment

Proactive identification of regulatory vulnerabilities. Our deep-dive audits provide a clear roadmap for remediation before the FDA arrives at your door.

Marketplace Compliance & Certification

Specialized protocols to protect and restore Amazon listings. We bridge the gap between technical cGMP standards and the documentation required for marketplace stability.

Strategic Advisory

Regulatory Due Diligence

Technical risk assessment for M&A and private equity. We provide investors with an unvarnished look at a target's regulatory health and future compliance liabilities.

Technical Litigation Support

Authoritative expert testimony for regulatory and product liability matters. We translate complex FDA requirements into clear, defensible evidence for legal proceedings.

Is this your situation?

Enforcement & Crisis

FDA Enforcement Actions

You have received an FDA 483 or Warning Letter and require an immediate, defensible response strategy to protect your license to operate.

Marketplace Suspensions

Your Amazon listings or revenue are at risk of suspension due to critical compliance documentation or testing gaps.

Urgent Audit Preparation

Your quality systems are not inspection-ready, and a regulatory or third-party audit is fast approaching.

Growth & Operations

Strategic Due Diligence

You are evaluating a target acquisition and require independent regulatory due diligence to quantify investment risks.

New Product Launch

You are bringing a new product line to market and need to ensure compliant labeling, claims, and technical documentation.

Facility & Process Validation

Your manufacturing facility requires robust process validation or cleaning validation programs to meet cGMP standards.

Supply Chain & Legal

Contract Manufacturing Oversight

Your contract manufacturer requires a third-party quality audit or gap assessment before you can safely release product.

Expert Litigation Support

Your legal team requires expert witness support for complex regulatory disputes or product liability litigation.

Regulatory Inspection Readiness

You are preparing for a formal regulatory inspection and need a mock audit to identify and remediate vulnerabilities.

Proven Results

Select engagements that demonstrate our approach and impact.

Quality Systems

FDA Remediation

Rebuilt an entire quality management system for a dietary supplement manufacturer following FDA enforcement action. Resolved all findings and achieved full inspection readiness within 90 days.

Strategic Advisory

Acquisition Due Diligence

Conducted comprehensive regulatory due diligence for a private equity firm evaluating a multi-facility supplement manufacturer. Risk assessment directly informed the investment decision.

Amazon Compliance

Amazon Compliance Recovery

Restored suspended Amazon listings for a supplement brand by building compliant testing protocols, corrected labeling, and comprehensive documentation systems.

What colleagues say

From recommendations on Aisha's LinkedIn profile.

“She developed robust quality systems which ultimately led to higher quality products and overall reduction in quality incidents.”

Govani Ramirez

Sr. Manager, Warehouse and Distribution Quality, Nestlé Health Science

Reported to Aisha at The Nature's Bounty Co.

“Aisha has the vision to see what can be achieved and works diligently to improve the quality management systems in the organization. She has led factory quality and food safety teams in both packaging and manufacturing operations in the dietary supplement industry.”

David Largey

Owner, Food Safety and Quality Services LLC

Managed Aisha at The Nature's Bounty Co.

“Aisha was quickly able to bring together many of the technical elements driving the creation of a global certification management system.”

Noah Sheinwald

Quality Compliance Manager, Nestlé Health Science

Reported to Aisha at The Nature's Bounty Co.

Frequently asked questions

How long do I have to respond to an FDA Form 483?

FDA asks for a written response within 15 business days of the close of the inspection. A response received in that window can be considered before FDA decides whether to issue a Warning Letter, so the clock matters. A strong response addresses each observation with root cause, corrective actions, evidence and a timeline.

What does 21 CFR Part 111 require for dietary supplements?

Part 111 is the cGMP rule for dietary supplements. It covers personnel, facilities and equipment, written procedures, specifications and identity testing of components, master manufacturing and batch production records, quality control review, holding and distribution, returns, and complaint handling. FDA inspectors check that each requirement is documented and followed in practice.

What is the difference between a Form 483 and a Warning Letter?

A Form 483 lists observations an investigator made during an inspection. A Warning Letter is a formal notice from FDA that the agency considers the firm in significant violation, and it is usually public. An inadequate 483 response is one of the most common paths to a Warning Letter.

Why was my supplement listing suspended on Amazon?

Amazon requires dietary supplement sellers to show compliance with FDA labeling and cGMP rules, and it acts on claims, labels and testing documentation. Common triggers include disease claims, missing or inaccurate Supplement Facts, and an inability to provide third-party testing or a Certificate of Analysis. Reinstatement usually requires correcting the root cause and submitting documented proof.

Do you work with companies outside the US?

Yes. AQS works with international manufacturers exporting to the US, including supplier qualification and Foreign Supplier Verification Program (FSVP) support for importers.

How quickly can you start on an urgent FDA matter?

For urgent matters like 483s, Warning Letters or import alerts, work can usually begin within 24 to 48 hours.

Regulatory challenges don't wait. Neither should your response.

Whether your organization is facing an FDA enforcement action, preparing for an inspection, or building quality systems from the ground up, our team delivers expert-led solutions with urgency and precision.